Organigram Global (OGI) Convertible Debt (2018)
Organigram Global (OGI) reported Convertible Debt of $95.9 million for Q3 2018.
Organigram Global (OGI) Convertible Debt (2018) Analysis & Trends
Organigram Global (OGI) has 1 years of Convertible Debt data on file, last reported at $95.9 million in Q3 2018.
- Convertible Debt for Q3 2018 came in at $95.9 million, changed N/A year-over-year; the trailing twelve-month figure through Aug 2018 was $95.9 million (changed N/A YoY), and the FY2018 annual result was $95.9 million, changed N/A from the prior year.
- Convertible Debt was little changed at $95.9 million in Q3 2018 per OGI's latest filing.
- Over five years, Convertible Debt peaked at $95.9 million in Q3 2018 and troughed at $95.9 million in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Organigram Global | 731.20 Mn | 673.26 Mn | 11.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2018 | 95.87 Mn |